NASDAQ:DORM • US2582781009
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DORMAN PRODUCTS INC (DORM).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-05 | Barrington Research | Maintains | Outperform -> Outperform |
| 2026-03-02 | Jefferies | Upgrade | Hold -> Buy |
| 2026-02-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-30 | Stephens & Co. | Initiate | Overweight |
| 2025-09-18 | BMO Capital | Initiate | Outperform |
| 2025-08-26 | Roth Capital | Maintains | Buy -> Buy |
| 2025-08-22 | Wells Fargo | Initiate | Overweight |
| 2024-11-04 | Roth MKM | Reiterate | Buy -> Buy |
| 2024-06-14 | Roth MKM | Reiterate | Buy -> Buy |
| 2024-03-25 | Roth MKM | Reiterate | Buy -> Buy |
| 2024-02-27 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2023-07-28 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2023-05-03 | Barrington Research | Maintains | Outperform |
| 2023-05-03 | Stephens & Co. | Maintains | Equal-Weight |
| 2023-03-02 | Barrington Research | Maintains | Outperform |
| 2023-03-02 | Stephens & Co. | Maintains | Equal-Weight |
| 2022-10-25 | Barrington Research | Maintains | Outperform |
| 2022-10-25 | MKM Partners | Maintains | Buy |
| 2022-10-25 | Stephens & Co. | Maintains | Equal-Weight |
| 2022-08-22 | Stephens & Co. | Maintains | Equal-Weight |
| 2022-05-19 | MKM Partners | Initiate | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.734B 28.88% | 1.93B 11.31% | 2.009B 4.11% | 2.21B 9.99% | 2.33B 5.43% | 2.441B 4.76% | 2.606B 6.76% | 2.753B 5.64% | 2.908B 5.63% | |
| EBITDA YoY % growth | 215.7M 4.30% | 284.889M 32.08% | 349.609M 22.72% | 435.65M 24.61% | 433.09M -0.59% | 467.8M 8.01% | N/A | N/A | N/A | |
| EBIT YoY % growth | 171M -0.35% | 230.16M 34.60% | 292.909M 27.26% | 378.73M 29.30% | 403.73M 6.60% | 437.99M 8.49% | N/A | N/A | N/A | |
| Operating Margin | 9.86% | 11.93% | 14.58% | 17.14% | 17.33% | 17.94% | N/A | N/A | N/A | |
| EPS YoY % growth | 4.76 2.37% | 4.54 -4.62% | 7.14 57.27% | 9.01 24.23% | 8.95 0.95% | 9.86 10.09% | 8.83 -10.39% | 10.39 17.67% | 12.13 16.68% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.68 -16.75% | 2.10 1.86% | 2.52 -3.96% | 2.64 21.62% | 2.44 45.27% | 2.58 22.98% | 2.73 8.44% | 2.89 9.57% |
| Revenue Q2Q % growth | 539.92M 6.35% | 591.62M 9.37% | 580.77M 6.81% | 613.53M 14.05% | 568.11M 5.22% | 602.05M 1.76% | 609.25M 4.90% | 631.63M 2.95% |
| EBITDA Q2Q % growth | 88.052M -6.24% | 101.87M -7.60% | 118.21M -19.88% | 119.8M 13.64% | 112.03M 27.23% | 115.58M 13.46% | 117.86M -0.30% | 121.12M 1.10% |
| EBIT Q2Q % growth | 74.749M -6.65% | 90.249M 9.42% | 105.57M -0.17% | 109.64M 17.87% | 98.77M 32.14% | 102.5M 13.57% | 104.93M -0.61% | 108.34M -1.19% |
All data in USD
14 analysts have analysed DORM and the average price target is 173.78 USD. This implies a price increase of 71.55% is expected in the next year compared to the current price of 101.3.
DORMAN PRODUCTS INC (DORM) will report earnings on 2026-05-04.
The consensus EPS estimate for the next earnings of DORMAN PRODUCTS INC (DORM) is 1.68 USD and the consensus revenue estimate is 539.92M USD.
The consensus rating for DORMAN PRODUCTS INC (DORM) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.